{"id":"https://openalex.org/W7225634569","doi":"https://doi.org/10.1111/dom.71534","title":"Two\u2010Year Trajectories of DIAL2 \u2010Predicted Cardiovascular Risk After Initiation of Semaglutide, Empagliflozin or Their Combination: The DIAL \u2010 STEP Study","display_name":"Two\u2010Year Trajectories of DIAL2 \u2010Predicted Cardiovascular Risk After Initiation of Semaglutide, Empagliflozin or Their Combination: The DIAL \u2010 STEP Study","publication_year":2026,"publication_date":"2026-11-09","ids":{"openalex":"https://openalex.org/W7225634569","doi":"https://doi.org/10.1111/dom.71534","pmid":"https://pubmed.ncbi.nlm.nih.gov/43003421"},"language":"en","primary_location":{"id":"doi:10.1111/dom.71534","doi":"https://doi.org/10.1111/dom.71534","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.71534","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.71534","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.71534","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5122844678","display_name":"Antonio Maria Labate","orcid":"https://orcid.org/0009-0006-4619-6565","observed_orcids":["https://orcid.org/0009-0006-4619-6565"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Antonio Maria Labate","raw_affiliation_strings":["ASST Mantova Servizio di Specialistica Ambulatoriale, Branca Diabetologia, Casa di Comunit\u00e0 di Goito  Mantova Italy"],"raw_orcid":"https://orcid.org/0009-0006-4619-6565","affiliations":[{"raw_affiliation_string":"ASST Mantova Servizio di Specialistica Ambulatoriale, Branca Diabetologia, Casa di Comunit\u00e0 di Goito  Mantova Italy","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051592766","display_name":"Provvidenza Villari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4396570588","display_name":"Azienda Socio Sanitaria Territoriale del Garda","ror":"https://ror.org/01fp9aw72","country_code":"IT","type":"government","lineage":["https://openalex.org/I4396570588"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Provvidenza Villari","raw_affiliation_strings":["ASST Garda Specialistica Ambulatoriale \u2013 Branca Diabetologia, Localit\u00e0 Montecroce  Desenzano del Garda Brescia Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ASST Garda Specialistica Ambulatoriale \u2013 Branca Diabetologia, Localit\u00e0 Montecroce  Desenzano del Garda Brescia Italy","institution_ids":["https://openalex.org/I4396570588"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5122844678"],"corresponding_institution_ids":[],"apc_list":{"value":5380,"currency":"USD","value_usd":5380},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cardiovascular-risk-prediction","display_name":"cardiovascular risk prediction","score":0.9710000157356262},{"id":"https://openalex.org/keywords/semaglutide","display_name":"semaglutide","score":0.9829999804496765},{"id":"https://openalex.org/keywords/empagliflozin","display_name":"empagliflozin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.7889999747276306},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9229999780654907},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.621999979019165},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8009999990463257},{"id":"https://openalex.org/keywords/risk-trajectories","display_name":"risk trajectories","score":0.6259999871253967},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.6880000233650208},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.9269999861717224},{"id":"https://openalex.org/keywords/cholesterol","display_name":"cholesterol","score":0.753000020980835},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.8550000190734863},{"id":"https://openalex.org/keywords/age-effects","display_name":"age effects","score":0.42899999022483826},{"id":"https://openalex.org/keywords/shapley-decomposition","display_name":"Shapley decomposition","score":0.7540000081062317}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9508000016212463},{"id":"https://openalex.org/C2775887513","wikidata":"https://www.wikidata.org/wiki/Q5373824","display_name":"Empagliflozin","level":4,"score":0.8508999943733215},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5256999731063843},{"id":"https://openalex.org/C5274069","wikidata":"https://www.wikidata.org/wiki/Q2285707","display_name":"Categorical variable","level":2,"score":0.5241000056266785},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.5092999935150146},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.451200008392334},{"id":"https://openalex.org/C2983394010","wikidata":"https://www.wikidata.org/wiki/Q19885330","display_name":"Continuous variable","level":2,"score":0.4296000003814697},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.41449999809265137},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.4120999872684479},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.40639999508857727},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.40630000829696655},{"id":"https://openalex.org/C12174686","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk assessment","level":2,"score":0.36489999294281006},{"id":"https://openalex.org/C50440223","wikidata":"https://www.wikidata.org/wiki/Q1475848","display_name":"Risk factor","level":2,"score":0.35100001096725464},{"id":"https://openalex.org/C26831200","wikidata":"https://www.wikidata.org/wiki/Q16963953","display_name":"Marginal structural model","level":3,"score":0.3481000065803528},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3452000021934509},{"id":"https://openalex.org/C11783203","wikidata":"https://www.wikidata.org/wiki/Q5478027","display_name":"Framingham Risk Score","level":3,"score":0.335099995136261},{"id":"https://openalex.org/C82789193","wikidata":"https://www.wikidata.org/wiki/Q2142611","display_name":"Relative risk","level":3,"score":0.3183000087738037},{"id":"https://openalex.org/C77350462","wikidata":"https://www.wikidata.org/wiki/Q1125472","display_name":"Confounding","level":2,"score":0.3181999921798706},{"id":"https://openalex.org/C119043178","wikidata":"https://www.wikidata.org/wiki/Q320723","display_name":"Covariate","level":2,"score":0.30640000104904175},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.303600013256073},{"id":"https://openalex.org/C2909478654","wikidata":"https://www.wikidata.org/wiki/Q844935","display_name":"Atherosclerotic cardiovascular disease","level":3,"score":0.29919999837875366},{"id":"https://openalex.org/C27403532","wikidata":"https://www.wikidata.org/wiki/Q5532474","display_name":"Generalized estimating equation","level":2,"score":0.28760001063346863},{"id":"https://openalex.org/C2779668873","wikidata":"https://www.wikidata.org/wiki/Q6693756","display_name":"Lower risk","level":3,"score":0.2773999869823456},{"id":"https://openalex.org/C120195587","wikidata":"https://www.wikidata.org/wiki/Q2138790","display_name":"Absolute risk reduction","level":3,"score":0.27250000834465027},{"id":"https://openalex.org/C3018284874","wikidata":"https://www.wikidata.org/wiki/Q389735","display_name":"Cardiovascular health","level":3,"score":0.2567000091075897},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.2547999918460846},{"id":"https://openalex.org/C178853913","wikidata":"https://www.wikidata.org/wiki/Q1642137","display_name":"Hemodynamics","level":2,"score":0.25290000438690186}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1111/dom.71534","doi":"https://doi.org/10.1111/dom.71534","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.71534","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.71534","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmid:43003421","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/43003421","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/dom.71534","doi":"https://doi.org/10.1111/dom.71534","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.71534","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.71534","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225634569.pdf","grobid_xml":"https://content.openalex.org/works/W7225634569.grobid-xml"},"referenced_works_count":33,"referenced_works":["https://openalex.org/W2146264128","https://openalex.org/W2170271198","https://openalex.org/W2519510391","https://openalex.org/W2519803668","https://openalex.org/W2626446274","https://openalex.org/W2887342240","https://openalex.org/W2899764361","https://openalex.org/W2900413769","https://openalex.org/W2918407168","https://openalex.org/W2973090108","https://openalex.org/W3081830235","https://openalex.org/W3088173406","https://openalex.org/W3165900016","https://openalex.org/W3166015112","https://openalex.org/W3193297191","https://openalex.org/W3195404919","https://openalex.org/W4206445899","https://openalex.org/W4220661538","https://openalex.org/W4303684924","https://openalex.org/W4308183941","https://openalex.org/W4320855956","https://openalex.org/W4361219083","https://openalex.org/W4378746292","https://openalex.org/W4386151915","https://openalex.org/W4388592674","https://openalex.org/W4393054462","https://openalex.org/W4395446333","https://openalex.org/W4398781461","https://openalex.org/W4402066452","https://openalex.org/W4406730283","https://openalex.org/W4408960945","https://openalex.org/W4410875865","https://openalex.org/W4417121408"],"related_works":["https://openalex.org/W4411335785","https://openalex.org/W4411335763","https://openalex.org/W7140288748","https://openalex.org/W3046216547","https://openalex.org/W4416945779","https://openalex.org/W4307379091","https://openalex.org/W7128077061","https://openalex.org/W4390588722","https://openalex.org/W4406636348","https://openalex.org/W4207077301"],"abstract_inverted_index":{"AIMS:":[0],"To":[1],"describe":[2],"observed":[3],"clinical":[4],"changes":[5,90,187,214],"and":[6,61,73,82,116,130,140,193,215,220],"trajectories":[7],"of":[8,15,232],"DIAL2-predicted":[9],"cardiovascular":[10,33,228],"risk":[11,51,55,167,197],"during":[12,200],"24":[13,182],"months":[14,183],"oral":[16],"semaglutide,":[17],"empagliflozin":[18],"or":[19,77,230],"combination":[20],"treatment.":[21],"MATERIALS":[22],"AND":[23],"METHODS:":[24],"This":[25],"retrospective":[26],"cohort":[27],"included":[28,91],"332":[29],"adults":[30],"without":[31,142],"prior":[32],"disease":[34],"(semaglutide,":[35],"139;":[36],"empagliflozin,":[37],"106;":[38],"combination,":[39],"87).":[40],"The":[41,149],"primary":[42],"endpoint":[43],"was":[44,56,125,137,152],"the":[45],"investigator-defined":[46],"HIGH":[47,135],"category":[48],"(calculated":[49],"1-year":[50],"\u2265":[52],"3%);":[53],"continuous":[54,209],"secondary.":[57],"Generalized":[58],"estimating":[59],"equations":[60],"linear":[62],"mixed":[63],"models":[64,68],"assessed":[65],"trajectories.":[66],"Sensitivity":[67],"added":[69],"baseline":[70,78],"age,":[71],"sex":[72],"their":[74],"time":[75],"interactions":[76],"predicted":[79,166],"risk.":[80],"Age-fixed":[81],"Shapley":[83],"calculations":[84],"were":[85],"exploratory.":[86],"RESULTS:":[87],"Paired":[88],"24-month":[89],"HbA1c":[92],"-1.13":[93],"percentage":[94],"points":[95],"(95%":[96],"CI:":[97],"-1.27":[98],"to":[99,107,114,121,171],"-1.00),":[100],"systolic":[101],"blood":[102],"pressure":[103],"-7.64":[104],"mmHg":[105],"(-9.48":[106],"-5.79),":[108],"total":[109],"cholesterol":[110],"-20.28":[111],"mg/dL":[112],"(-23.84":[113],"-16.73)":[115],"weight":[117],"-3.91":[118],"kg":[119],"(-4.40":[120],"-3.41).":[122],"Standard":[123],"DIAL2":[124,203,219],"valid":[126],"for":[127],"329,":[128],"327":[129],"325":[131],"participants":[132],"across":[133],"visits.":[134],"prevalence":[136],"24.6%,":[138],"23.2%":[139],"23.7%,":[141],"a":[143,233],"time-by-treatment":[144],"interaction":[145,151],"(p":[146,154],"=":[147,155,159],"0.731).":[148],"continuous-risk":[150],"significant":[153],"0.002;":[156],"demographic-time-adjusted":[157],"p":[158],"0.006).":[160],"In":[161],"324":[162],"complete":[163],"cases,":[164],"standard":[165],"changed":[168],"from":[169],"2.172%":[170],"2.052%":[172],"(relative":[173],"change":[174],"-5.5%);":[175],"holding":[176],"age":[177],"fixed":[178],"yielded":[179],"1.777%":[180],"at":[181],"(-18.2%).":[184],"These":[185],"relative":[186],"concern":[188],"calculated":[189],"probabilities.":[190],"CONCLUSIONS:":[191],"Glycaemia":[192],"several":[194],"other":[195],"measured":[196],"factors":[198],"improved":[199],"follow-up.":[201],"Categorical":[202],"status":[204],"remained":[205],"broadly":[206],"stable,":[207],"while":[208],"estimates":[210],"varied":[211],"with":[212],"risk-factor":[213],"chronological":[216],"age.":[217],"Repeated":[218],"its":[221],"explanatory":[222],"decompositions":[223],"do":[224],"not":[225],"establish":[226],"fewer":[227],"events":[229],"superiority":[231],"treatment":[234],"strategy.":[235]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-10T00:00:00"}